Synergistic effect of clinically available β lactamases inhibitors on cefiderocol activity against carbapenemase producing Gram negative organisms. Microbiologia Medica, [S. l.], v. 38, n. 1, 2023. DOI: 10.4081/mm.2023.11367. Disponível em: https://www.pagepressjournals.org/mm/article/view/11367. Acesso em: 7 may. 2026.